Tamara Pringsheim

Summary

Affiliation: University of Calgary
Country: Canada

Publications

  1. ncbi Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
    Can J Psychiatry 57:722-7. 2012
  2. ncbi Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta
    Can J Psychiatry 57:133-43. 2012
  3. ncbi The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
    Mov Disord 27:1083-91. 2012
  4. ncbi The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Canada
    J Child Adolesc Psychopharmacol 21:537-43. 2011
  5. ncbi The pharmacoepidemiology of antipsychotics for adults with schizophrenia in Canada, 2005 to 2009
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Alberta
    Can J Psychiatry 56:630-4. 2011
  6. ncbi Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth
    Tamara Pringsheim
    The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children CAMESA Guideline Project
    J Can Acad Child Adolesc Psychiatry 20:218-33. 2011
  7. ncbi Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials
    Tamara Pringsheim
    University of Calgary, Calgary, AB, Canada
    Drug Saf 34:651-68. 2011
  8. ncbi Complications of antipsychotic therapy in children with tourette syndrome
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta, Canada
    Pediatr Neurol 43:17-20. 2010
  9. ncbi Prenatal and perinatal morbidity in children with Tourette syndrome and attention-deficit hyperactivity disorder
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta, Canada
    J Dev Behav Pediatr 30:115-21. 2009
  10. ncbi Canadian Headache Society guideline for migraine prophylaxis
    Tamara Pringsheim
    University of Calgary and the Hotchkiss Brain Institute, Calgary, AB, Canada
    Can J Neurol Sci 39:S1-59. 2012

Detail Information

Publications10

  1. ncbi Second-generation antipsychotics for the treatment of disruptive behaviour disorders in children: a systematic review
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
    Can J Psychiatry 57:722-7. 2012
    ..Increases are mainly attributable to treatment of disruptive behaviour disorders (DBDs). Our objective was to review the evidence regarding the efficacy of SGAs for DBDs in youth...
  2. ncbi Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta
    Can J Psychiatry 57:133-43. 2012
    ..However, when tics are more distressing and interfering, the need for tic suppression to improve quality of life is stronger, and patients and clinicians may be more willing to accept the risks of pharmacotherapy...
  3. ncbi The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
    Mov Disord 27:1083-91. 2012
    ..HD is a devastating neurodegenerative disorder with a higher prevalence in Europe, North America, and Australia than in Asia. The difference in prevalence of this genetic disorder can be largely explained by huntingtin gene haplotypes...
  4. ncbi The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Canada
    J Child Adolesc Psychopharmacol 21:537-43. 2011
    ..To describe the frequency and trends of use of antipsychotics in Canadian children and adolescents from 2005 to 2009...
  5. ncbi The pharmacoepidemiology of antipsychotics for adults with schizophrenia in Canada, 2005 to 2009
    Tamara Pringsheim
    Department of Clinical Neurosciences, University of Calgary, Alberta
    Can J Psychiatry 56:630-4. 2011
    ..To describe the frequency and trends in the use of antipsychotics for adults with schizophrenia in Canada from 2005 to 2009...
  6. ncbi Evidence-based recommendations for monitoring safety of second generation antipsychotics in children and youth
    Tamara Pringsheim
    The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children CAMESA Guideline Project
    J Can Acad Child Adolesc Psychiatry 20:218-33. 2011
    ..These medications have the potential to cause major metabolic and neurological complications with chronic use...
  7. ncbi Metabolic and neurological complications of second-generation antipsychotic use in children: a systematic review and meta-analysis of randomized controlled trials
    Tamara Pringsheim
    University of Calgary, Calgary, AB, Canada
    Drug Saf 34:651-68. 2011
    ..Given the demonstrated metabolic and neurological adverse effects seen in adult patients on these medications, detailed evaluation of the risk for these adverse effects in children is appropriate...
  8. ncbi Complications of antipsychotic therapy in children with tourette syndrome
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta, Canada
    Pediatr Neurol 43:17-20. 2010
    ..Neurologic complications are uncommon, which is likely attributable to the primary use of atypical antipsychotics in this setting...
  9. ncbi Prenatal and perinatal morbidity in children with Tourette syndrome and attention-deficit hyperactivity disorder
    Tamara Pringsheim
    Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta, Canada
    J Dev Behav Pediatr 30:115-21. 2009
    ..Low birth weight is a known risk factor for ADHD. The objective of the study was to assess the association between pre- and perinatal morbidity and the comorbid diagnosis of ADHD in children with TS...
  10. ncbi Canadian Headache Society guideline for migraine prophylaxis
    Tamara Pringsheim
    University of Calgary and the Hotchkiss Brain Institute, Calgary, AB, Canada
    Can J Neurol Sci 39:S1-59. 2012
    ..This guideline is focused on patients with episodic migraine (headache on ≤ 14 days a month)...